NASDAQ:KMTS Kestra Medical Technologies (KMTS) Stock Price, News & Analysis $28.60 -0.02 (-0.06%) Closing price 03:59 PM EasternExtended Trading$28.73 +0.13 (+0.44%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOwnershipSEC FilingsShort Interest About Kestra Medical Technologies Stock (NASDAQ:KMTS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get KMTS alerts:Sign Up Key Stats Today's Range$27.86▼$29.1250-Day Range$22.85▼$31.6352-Week Range$17.34▼$31.99Volume238,922 shsAverage Volume362,506 shsMarket Capitalization$1.70 billionP/E RatioN/ADividend YieldN/APrice Target$29.00Consensus RatingModerate Buy Company Overview Kestra Medical Technologies is a medical technology company focused on wearable solutions for people at risk of sudden cardiac arrest. Its products combine cardiac monitoring, treatment technology and digital services intended to support patients and their care teams. The company’s flagship product, the ASSURE wearable cardioverter defibrillator, continuously monitors a patient’s heart rhythm and can deliver a treatment shock if it detects a life-threatening arrhythmia. The system also provides alerts and supports remote sharing of patient data with clinicians. Based in Kirkland, Washington, Kestra serves the U.S. market through its wearable cardiac device and related patient-monitoring and support services.AI Generated. May Contain Errors. Read More Kestra Medical Technologies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks25th Percentile Overall ScoreKMTS MarketRank™: 1.259487045275 of 5 starsKestra Medical Technologies scored higher than 25% of companies evaluated by MarketBeat, and ranked 813th out of 892 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.2 / 5Analyst RatingModerate Buy Consensus RatingKestra Medical Technologies has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 5 buy ratings, 2 hold ratings, and 1 sell rating.Upside/DownsideThe consensus price target for Kestra Medical Technologies is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageKestra Medical Technologies has only been the subject of 4 research reports in the past 90 days.Read more about Kestra Medical Technologies' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Kestra Medical Technologies are expected to grow in the coming year, from ($2.45) to ($2.12) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Kestra Medical Technologies is -10.71, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Kestra Medical Technologies is -10.71, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioKestra Medical Technologies has a P/B Ratio of 6.43. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted7.28% of the float of Kestra Medical Technologies has been sold short.Short Interest Ratio / Days to CoverKestra Medical Technologies has a short interest ratio ("days to cover") of 8.15.Change versus previous monthShort interest in Kestra Medical Technologies has recently increased by 19.69%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldKestra Medical Technologies does not currently pay a dividend.Dividend GrowthKestra Medical Technologies does not have a long track record of dividend growth. News and Social Media3.0 / 5News Sentiment0.74 News SentimentKestra Medical Technologies has a news sentiment score of 0.74. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Kestra Medical Technologies this week, compared to 4 articles on an average week.MarketBeat FollowsOnly 1 people have added Kestra Medical Technologies to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Company Ownership0.9 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Kestra Medical Technologies insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $7,585,946.00 in company stock.Percentage Held by Insiders5.30% of the stock of Kestra Medical Technologies is held by insiders.Percentage Held by InstitutionsKestra Medical Technologies has minimal institutional ownership at this time.Read more about Kestra Medical Technologies' insider trading history. Receive KMTS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Kestra Medical Technologies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. KMTS Stock News HeadlinesKestra Medical Technologies (NASDAQ:KMTS) Rating Lowered to "Sell" at Wall Street ZenNovember 8, 2026 | americanbankingnews.comInsider Selling: Kestra Medical Technologies (NASDAQ:KMTS) Insider Sells $94,355.52 in StockNovember 6, 2026 | insidertrades.comURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards urges homeowners to check the map and see whether one is near them. Families in Georgia have been forced to sell, entire Ohio neighborhoods are being torn down, and nearly 50,000 Lake Tahoe residents face losing power. Rickards advised the Pentagon and the U.S. intelligence community for decades. He says one man outside Washington can stop it.November 13 at 1:00 AM | Paradigm Press (Ad)KMTS - Kestra Medical Technologies, Ltd.November 5, 2026 | seekingalpha.comKestra Medical Technologies Ltd. (KMTS) Receives a Buy from Piper SandlerNovember 5, 2026 | theglobeandmail.comKestra Medical Technologies to Participate in Upcoming Investor ConferencesOctober 30, 2026 | globenewswire.comKestra Medical Technologies (NASDAQ:KMTS) Stock: Insider Vaseem Mahboob Sells 4,788 SharesOctober 30, 2026 | insidertrades.comKestra Medical Technologies (NASDAQ:KMTS) Insider Sells 15,000 Shares of StockOctober 23, 2026 | insidertrades.comSee More Headlines KMTS Stock Analysis - Frequently Asked Questions How have KMTS shares performed this year? Kestra Medical Technologies' stock was trading at $26.52 at the beginning of the year. Since then, KMTS stock has increased by 7.9% and is now trading at $28.6190. How were Kestra Medical Technologies' earnings last quarter? Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) announced its earnings results on Monday, September, 14th. The company reported ($0.75) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.61) by $0.14. The business earned $30.97 million during the quarter. Kestra Medical Technologies had a negative net margin of 140.43% and a negative trailing twelve-month return on equity of 63.83%. Read the conference call transcript. When did Kestra Medical Technologies IPO? Kestra Medical Technologies (KMTS) raised $178 million in an IPO on Thursday, March 6th 2025. The company issued 11,882,352 shares at $14.00-$16.00 per share. Who are Kestra Medical Technologies' major shareholders? Kestra Medical Technologies' top institutional shareholders include State Street Corp (1.31%), First Trust Advisors LP (0.53%), Mirae Asset Global Investments Co. Ltd. (0.02%) and Global Retirement Partners LLC. Insiders that own company stock include Brian Daniel Webster, Traci S Umberger, Alfred J Ford Jr, Timothy P Moran, Vaseem Mahboob, Raymond W Cohen, Mary Kay Ladone, Elizabeth Kwo, Jeffrey Lawrence Schwartz, Conor Hanley and Kevin C Reilly. View institutional ownership trends. How do I buy shares of Kestra Medical Technologies? Shares of KMTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings9/14/2026Today11/13/202638th Annual Healthcare Conference12/01/2026Fiscal Year End4/30/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (8m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 KMTS's financial health is in the Green zone, according to TradeSmith. KMTS has been in this zone for over 8 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:KMTS Previous SymbolNASDAQ:KMTS CIK1877184 Webwww.kestramedical.com Phone(425) 279-8002FaxN/AEmployees443Year Founded2021Price Target and Rating Average Price Target for Kestra Medical Technologies$29.00 High Price Target$34.00 Low Price Target$17.00 Potential Upside/Downside+1.6%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage8 Analysts Profitability EPS (Trailing Twelve Months)($2.67) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$131.61 million Net Margins-140.43% Pretax Margin-140.14% Return on Equity-63.83% Return on Assets-44.76% Debt Debt-to-Equity Ratio0.33 Current Ratio4.69 Quick Ratio4.69 Sales & Book Value Annual Sales$95.13 million Price / Sales17.87 Cash FlowN/A Price / Cash FlowN/A Book Value$4.45 per share Price / Book6.42Miscellaneous Outstanding Shares59,560,000Free Float56,405,000Market Cap$1.70 billion OptionableN/A Beta0.45 The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (NASDAQ:KMTS) was last updated on 11/13/2026 by MarketBeat.com Staff. From Our PartnersTrump’s EO to send this $5 stock ripping higher…?President Trump's December executive order declared space a national security and economic priority, fueling a...Traders Agency | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredUranium Mine Flood That Sparked a 2006 Price Surge ReturnsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...Digest Publishing | SponsoredA little-known law has been quietly applied to your savings for years.Fox News reported that under current law, legal title to most stocks and bonds sits with a central institution...Monetary Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kestra Medical Technologies, Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kestra Medical Technologies With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
